Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA204110
Max Phase: Preclinical
Molecular Formula: C9H14N2OS
Molecular Weight: 198.29
Molecule Type: Small molecule
Associated Items:
ID: ALA204110
Max Phase: Preclinical
Molecular Formula: C9H14N2OS
Molecular Weight: 198.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1c(O)nsc1C1CCNCC1
Standard InChI: InChI=1S/C9H14N2OS/c1-6-8(13-11-9(6)12)7-2-4-10-5-3-7/h7,10H,2-5H2,1H3,(H,11,12)
Standard InChI Key: TVYLWJFICSYNFD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 198.29 | Molecular Weight (Monoisotopic): 198.0827 | AlogP: 1.62 | #Rotatable Bonds: 1 |
Polar Surface Area: 45.15 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.06 | CX Basic pKa: 9.93 | CX LogP: 1.34 | CX LogD: 1.34 |
Aromatic Rings: 1 | Heavy Atoms: 13 | QED Weighted: 0.72 | Np Likeness Score: -0.46 |
1. Krehan D, Storustovu SI, Liljefors T, Ebert B, Nielsen B, Krogsgaard-Larsen P, Frølund B.. (2006) Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology., 49 (4): [PMID:16480274] [10.1021/jm050987l] |
Source(1):